Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Pharmacologic Treatment of COPD

만성 폐쇄성 폐질환의 약물치료

  • Chang, Joon (Department of Internal Medicine, Yonsei University College of Medicine)
  • 장준 (연세대학교 의과대학 내과학교실)
  • Published : 2005.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, manageꠀ ment, and prevention of chronic obstructive pulmoꠀ nary disease. Am J Respir Crit Care Med 2001;163: 1256-76
  2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932- 46 https://doi.org/10.1183/09031936.04.00014304
  3. The National Collaborating Center for Chronic Conꠀ ditions. Chronic obstructive pulmonary disease: naꠀ tional clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl I):1-232
  4. Donohue JF. Therapeutic responses in asthma and COPD: bronchodilators. Chest 2004;126:125S-37S https://doi.org/10.1378/chest.126.2_suppl_1.125S
  5. Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, et al. A 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotroꠀ pium or salmeterol. Chest 2002;122:47-55 https://doi.org/10.1378/chest.122.1.47
  6. Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatꠀ ment for six months with once daily tiotropium comꠀ pared with twice daily salmeterol in patients with COPD. Thorax 2003;58:399-404 https://doi.org/10.1136/thorax.58.5.399
  7. Tashkin DP, Cooper CB. The role of long-acting broꠀ nchodilators in the management of stable COPD. Chest 2004;125:249-59 https://doi.org/10.1378/chest.125.1.249
  8. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viꠀ skum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353:1819-23 https://doi.org/10.1016/S0140-6736(98)10019-3
  9. Pauwels RA, Lofdahl C, Laitinen LS, Schouten JP, Postma DS, Pride NB, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999;340:1948-53 https://doi.org/10.1056/NEJM199906243402503
  10. Burge PS, Calverley PM, Jones PW, Spencer S, Anderꠀ son JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. BMJ 2000;320: 1297-303 https://doi.org/10.1136/bmj.320.7245.1297
  11. Lung Health Study. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obsꠀ tructive pulmonary disease. N Engl J Med 2000;343: 1902-9 https://doi.org/10.1056/NEJM200012283432601
  12. Szafranski W, Cukier A, Ramirez A, Menga G, Sanꠀ sores R, Nahabedian S, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003;21: 74-81 https://doi.org/10.1183/09031936.03.00031402
  13. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361:449-56 https://doi.org/10.1016/S0140-6736(03)12459-2
  14. Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peꠀ terson S, Olsson H. Maintenance therapy with budeꠀ sonide and formoterol in chronic obstructive pulmoꠀ nary disease. Eur Respir J 2003;22:912-9 https://doi.org/10.1183/09031936.03.00027003